These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3114525)

  • 1. Antithrombotic and ulcerogenic effects of fenflumizole, a new anti-inflammatory imidazole derivative, in rats.
    Nabata H; Uchino M; Okazaki A; Yamazaki T; Sakai K
    Jpn J Pharmacol; 1987 May; 44(1):93-6. PubMed ID: 3114525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics and toxicology of fenflumizole, a new non-steroidal anti-inflammatory imidazole derivative.
    Corell T; Hasselmann G
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):288-96. PubMed ID: 6650179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet effects of fenflumizole, a new anti-inflammatory drug, in dogs.
    Nabata H; Uchino M; Okazaki A; Sakai K
    Jpn J Pharmacol; 1987 May; 44(1):97-100. PubMed ID: 3626187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenflumizole: interactions with the arachidonic acid cascade.
    Corell T; Hasselmann G; Splawinski J; Wojtaszek B
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):297-303. PubMed ID: 6417973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fenflumizole on aggregation ex vivo of human platelets and formation of thromboxane B2 and 6-keto-prostaglandin-F1 alpha.
    Vinge E; Corell T; Andersson KE
    Eur J Clin Pharmacol; 1984; 26(6):711-7. PubMed ID: 6436029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a new anti-inflammatory imidazole derivative, fenflumizole, on platelet aggregation in the rabbit.
    Aono J; Nabata H; Sakai K
    Jpn J Pharmacol; 1986 Dec; 42(4):575-8. PubMed ID: 3100849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of fenflumizole on platelet aggregation in patients with unstable angina pectoris.
    Grauholt AM; Grande P; Wadt J
    Eur J Clin Pharmacol; 1987; 31(5):547-51. PubMed ID: 2951260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of fenflumizole on platelet aggregation in man.
    Grande P; Wadt J; Corell T
    Eur J Clin Pharmacol; 1984; 27(2):169-72. PubMed ID: 6437841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of repeated oral doses of fenflumizole on platelet aggregation and thromboxane formation in man ex vivo.
    Dahl-Puustinen ML; Corell T; Koch K; Puustinen T
    Prostaglandins Leukot Essent Fatty Acids; 1988 Feb; 31(2):101-6. PubMed ID: 3357910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new anti-inflammatory derivative of imidazole which is less ulcerogenic than indomethacin in rats.
    Corell T; Jensen KM; Splawinski J
    Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):232-9. PubMed ID: 388981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the pharmacokinetics of fenflumizole, a novel antiinflammatory agent, after single oral administration to healthy subjects.
    Midskov C; Vinge E; Andersson KE
    Acta Pharmacol Toxicol (Copenh); 1984 May; 54(5):408-13. PubMed ID: 6464785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural damage and changes in eicosanoid metabolites in the gastric mucosa of rats and pigs induced by anti-inflammatory drugs of varying ulcerogenicity.
    Rainsford KD
    Int J Tissue React; 1986; 8(1):1-14. PubMed ID: 3949439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological studies on proglumetacin maleate, a new non-steroidal anti-inflammatory drug. (3) Damaging effects on the gastrointestinal tract].
    Ono N; Yamasaki Y; Yamamoto N; Sunami A; Miyake H
    Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):205-13. PubMed ID: 3098653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition by fenflumizole tissue cyclooxygenase in rabbits ex vivo.
    Basista M; Grodzińska L; Gryglewski RJ
    Pol J Pharmacol Pharm; 1985; 37(1):41-6. PubMed ID: 3929239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of 14C-fenflumizole after intravenous administration to man.
    Vinge E; Midskov C; Arnold E
    Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):355-62. PubMed ID: 3739729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory/anti-pyretic salicylic acid esters with low gastric ulcerogenic activity.
    Rainsford KD; Whitehouse MW
    Agents Actions; 1980 Nov; 10(5):451-6. PubMed ID: 6971045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxide chemistry of triaryl-substituted imidazoles. Fenflumizole, a non-steroidal, anti-inflammatory agent.
    Frandsen PL; Håkansson K; Holm A; Harrit N
    Acta Chem Scand (Cph); 1991 Jul; 45(6):627-31. PubMed ID: 1764333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of a new anti-inflammatory compound, alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), and its inhibitory effects on prostaglandin synthetase and 5-lipoxygenase.
    Hidaka T; Hosoe K; Ariki Y; Takeo K; Yamashita T; Katsumi I; Kondo H; Yamashita K; Watanabe K
    Jpn J Pharmacol; 1984 Sep; 36(1):77-85. PubMed ID: 6438380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiplatelet effects of the new antithrombotic agent aspalatone with low ulcerogenicity.
    Han BH; Suh DY; Yang HO; Park YH; Kang YH; Kim YC
    Arzneimittelforschung; 1994 Oct; 44(10):1122-6. PubMed ID: 7818584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.